Capital Advisors Inc. OK Has $60.47 Million Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Capital Advisors Inc. OK lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 5.9% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 122,086 shares of the medical equipment provider's stock after selling 7,665 shares during the period. Intuitive Surgical accounts for 1.2% of Capital Advisors Inc. OK's portfolio, making the stock its 20th largest holding. Capital Advisors Inc. OK's holdings in Intuitive Surgical were worth $60,466,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Atala Financial Inc bought a new position in shares of Intuitive Surgical in the fourth quarter worth about $25,000. Chilton Capital Management LLC increased its holdings in shares of Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock valued at $25,000 after purchasing an additional 43 shares in the last quarter. Parvin Asset Management LLC bought a new position in Intuitive Surgical in the 4th quarter worth approximately $26,000. Global Financial Private Client LLC lifted its holdings in Intuitive Surgical by 253.3% during the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock worth $26,000 after buying an additional 38 shares in the last quarter. Finally, Elite Financial Inc. bought a new position in Intuitive Surgical in the 1st quarter valued at $26,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Down 0.4%

Intuitive Surgical stock traded down $2.08 during midday trading on Thursday, hitting $526.05. 1,423,494 shares of the stock were exchanged, compared to its average volume of 1,673,063. The company has a fifty day simple moving average of $538.02 and a two-hundred day simple moving average of $536.87. Intuitive Surgical, Inc. has a 52 week low of $413.82 and a 52 week high of $616.00. The stock has a market capitalization of $188.55 billion, a PE ratio of 77.13, a P/E/G ratio of 5.59 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. The business had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same quarter last year, the firm earned $1.50 EPS. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Gary Loeb sold 1,700 shares of Intuitive Surgical stock in a transaction that occurred on Friday, April 25th. The shares were sold at an average price of $513.18, for a total value of $872,406.00. Following the transaction, the executive vice president owned 2,245 shares of the company's stock, valued at approximately $1,152,089.10. The trade was a 43.09% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Jami K. Nachtsheim sold 2,400 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the completion of the transaction, the director directly owned 6,371 shares in the company, valued at approximately $3,312,920. The trade was a 27.36% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 4,998 shares of company stock worth $2,611,577. Corporate insiders own 0.70% of the company's stock.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of recent research reports. Deutsche Bank Aktiengesellschaft downgraded Intuitive Surgical from a "hold" rating to a "sell" rating and dropped their target price for the stock from $515.00 to $440.00 in a research report on Monday, June 9th. Barclays dropped their price objective on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a report on Thursday, April 24th. BTIG Research set a $560.00 target price on shares of Intuitive Surgical and gave the company a "buy" rating in a research report on Monday, April 14th. Royal Bank Of Canada lowered their price target on shares of Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Finally, Truist Financial lowered their price target on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a research report on Wednesday, April 23rd. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical presently has an average rating of "Moderate Buy" and a consensus target price of $592.59.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.